IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
40.53%
1 Year Est. Return
+40.53%
AUM
$903M
AUM Growth
-$228M
(-20%)
Holding
109
Top Buys
| 1 | +$28.3M | |
| 2 | +$27.9M | |
| 3 | +$22.6M | |
| 4 |
Baxter International
BAX
|
+$17.1M |
| 5 |
Ascendis Pharma
ASND
|
+$15.6M |
Top Sells
| 1 | +$30.3M | |
| 2 | +$29.6M | |
| 3 | +$29.3M | |
| 4 |
Intuitive Surgical
ISRG
|
+$20.9M |
| 5 |
CVS Health
CVS
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Becton Dickinson
BDX
$53.3B
| $4.58M | 0.49% |
+20,000
|
|
||
52
Biohaven
BHVN
$1.76B
| $4.21M | 0.45% |
+175,000
|
|
||
53
Crinetics Pharmaceuticals
CRNX
$3.86B
| $4.19M | 0.45% |
125,000
-175,000
|
|
||
54
Scholar Rock
SRRK
$2.85B
| $4.02M | 0.43% |
125,000
-250,000
|
|
||
55
Alignment Healthcare
ALHC
$3.47B
| $3.72M | 0.4% |
200,000
-300,000
|
|
||
56
Globus Medical
GMED
$8.41B
| $3.66M | 0.39% |
+50,000
|
|
||
57
BioNTech
BNTX
$25.4B
| $3.64M | 0.39% |
40,000
-60,000
|
|
||
58
Catalyst Pharmaceutical
CPRX
$2.57B
| $3.64M | 0.39% |
150,000
-150,000
|
|
||
59
BridgeBio Pharma
BBIO
$10.4B
| $3.46M | 0.37% |
+100,000
|
|
||
60
Sana Biotechnology
SANA
$1.44B
| $3.36M | 0.36% |
2,000,000
|
|
||
61
Cigna
CI
$80.6B
| $3.29M | 0.35% |
+10,000
|
|
||
62
Nurix Therapeutics
NRIX
$1.12B
| $3.27M | 0.35% |
275,000
+25,000
|
|
||
63
Verastem
VSTM
$489M
| $3.02M | 0.32% |
+500,000
|
|
||
64
Oscar Health
OSCR
$4.99B
| $2.62M | 0.28% |
200,000
-500,000
|
|
||
65
Repligen
RGEN
$9.36B
| $2.54M | 0.27% |
20,000
-20,000
|
|
||
66
Jasper Therapeutics
JSPR
$66.2M
| $2.47M | 0.26% |
575,000
-75,000
|
|
||
67
Arrowhead Research
ARWR
$5.25B
| $2.23M | 0.24% |
175,000
-100,000
|
|
||
|
ATYR
68
aTyr Pharma
ATYR
$94.6M
| $2.11M | 0.22% |
700,000
+325,000
|
|
||
69
Terns Pharmaceuticals
TERN
$680M
| $1.93M | 0.21% |
700,000
+250,000
|
|
||
|
MREO
70
Mereo BioPharma
MREO
$318M
| $1.8M | 0.19% |
800,000
-200,000
|
|
||
71
Rezolute
RZLT
$835M
| $1.45M | 0.15% |
500,000
|
|
||
72
Cabaletta Bio
CABA
$226M
| $1.18M | 0.13% |
850,000
+350,000
|
|
||
73
Tenax Therapeutics
TENX
$33.7M
| $1.09M | 0.12% |
+167,000
|
|
||
74
Alto Neuroscience
ANRO
$340M
| $864K | 0.09% |
400,000
+100,000
|
|
||
|
PTN
75
DELISTED
Palatin Technologies
PTN
| $583K | 0.06% |
+1,000,000
|
|